Li et al (23) reported that individuals carrying ERCC1 rs11615 polymorphisms had an increased risk of mortality from gastric cancer compared with the risk of individuals carrying the common genotype, and this genetic polymorphism may contribute substantially to the future design of individualized treatments for gastric cancer patients. The gene discussed is ERCC1; the disease is gastric cancer.